Avidity Partners Management LP Sangamo Therapeutics, Inc Transaction History

Avidity Partners Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$1.66 - $3.67 $461,978 - $1.02 Million	-278,300 Reduced 10.13%	2,470,000 $4.35 Million
Q4 2022 Feb 14, 2023	BUY	$2.77 - $5.07 $1.07 Million - $1.96 Million	387,500 Added 16.41%	2,748,300 $8.63 Million
Q3 2022 Nov 14, 2022	BUY	$4.27 - $6.39 $10.1 Million - $15.1 Million	2,360,800 New	2,360,800 $11.6 Million

111

56.7M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $193M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

Stay updated on Avidity Partners Management LP with notifications on news.